3Pere Ginès,Juan Uriz,Blas Calahorra,Guadalupe Garcia–Tsao,Patrick S. Kamath,Luis Ruiz Del Arbol,Ramón Planas,Jaime Bosch,Vicente Arroyo,Juan Rodés.Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].Gastroenterology.2002(6)
4S?ren M?ller,Jens H. Henriksen.Cirrhotic cardiomyopathy[J].Journal of Hepatology.2010(1)
5Antonio Figueiredo,Francisco Romero-Bermejo,Rui Perdigoto,Paulo Marcelino,Mark T. Keegan.The End-Organ Impairment in Liver Cirrhosis: Appointments for Critical Care[J].Critical Care Research and Practice.2012
7Moreshwar S. Desai,Shabier Zainuer,Curtis Kennedy,Debra Kearney,John Goss,Saul J. Karpen.Cardiac Structural and Functional Alterations in Infants and Children With Biliary Atresia, Listed for Liver Transplantation[J].Gastroenterology.2011(4)
8William RFord,Stuart AHonan,RichardWhite,C RobinHiley.Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts[J].British Journal of Pharmacology.2009(5)
9Mireia Torregrosa,Santi Aguadé,Laura Dos,Rosa Segura,Antonio Gónzalez,Artur Evangelista,Joan Castell,Carlos Margarit,Rafael Esteban,Jaume Guardia,Joan Genescà.Cardiac alterations in cirrhosis: reversibility after liver transplantation[J].Journal of Hepatology.2004(1)
10John M. McCurley,Stephen U. Hanlon,Shao-kui Wei,Erich F. Wedam,Michael Michalski,Mark C. Haigney.Furosemide and the progression of left ventricular dysfunction in experimental heart failure[J].Journal of the American College of Cardiology.2004(6)
